Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials.
Yasmin Luz Lima MesquitaIsabela Reis MarquesIsabela R MarquesSara A CruzEduardo Messias Hirano PadrãoPedro Emanuel de Paula CarvalhoCaroliny Hellen Azevedo da SilvaRhanderson CardosoFilipe Azevedo MouraVladimir Vitalievich RafalskiyPublished in: International journal of obesity (2005) (2023)
CRD42022348576.